ITRM
NASDAQ
$0.18
Iterum Therapeutics Plc (ITRM)
Iterum Therapeutics plc, a clinical-stage pharmaceutical company, is engaged in the development of anti-infectives for multidrug resistant pathogens in Ireland and the United States. The company is headquartered in Dublin, Ireland.
Sector:
Healthcare
Industry:
Biotechnology
Strong Buy
Target: $9 (+5013.64%)
Market Cap
$8.06M
Beta (5Y)
1.11
Price Chart
Valuation
Market Cap$8.06M
Profitability
Total Revenue (TTM)$390K
Gross Profit (TTM)$116K
EBITDA-$43M
EPS-$0.81
Financial Health
Debt-to-Equity-271.6%
Growth & Risk
FCF 5Y CAGR-21.50%
Beta (5Y)1.11
Sharpe Ratio-1.64